Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Current Leases of $636000.0 for Q1 2026, up 39.47% year-over-year from $456000.0 in Q1 2025, and up 3.58% quarter-over-quarter from $614000.0 in Q4 2025.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Current Leases history runs 15 years deep, the most recent figure standing at $636000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 39.47% year-over-year to $636000.0; the TTM figure through Mar 2026 stood at $636000.0 (up 39.47% YoY), while the FY2025 annual figure was $614000.0, up 115.44% from the prior year.
- Current Leases for Q1 2026 stood at $636000.0, up from $614000.0 in the prior quarter.
- The five-year high for Current Leases was $8.3 million in Q1 2022, with the low at $285000.0 in Q4 2024.
- The 5-year median for Current Leases is $636000.0 (2026), against an average of $1.5 million.
- The sharpest annual moves came in 2023 and 2025: Current Leases tumbled 94.59% in 2023, then surged 115.44% in 2025.
- Rigel Pharmaceuticals' Current Leases stood at $1.1 million in 2022, then plunged by 38.92% to $692000.0 in 2023, then slumped by 58.82% to $285000.0 in 2024, then soared by 115.44% to $614000.0 in 2025, then rose by 3.58% to $636000.0 in 2026.
- Business Quant data shows RIGL's Current Leases at $636000.0 in Q1 2026, $614000.0 in Q4 2025, and $594000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Rigel Pharmaceuticals | 905.26 Mn | 809.94 Mn | 70.18 Mn | 656,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656,000.00 |
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 614,000.00 |
| Sep 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 517,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 466,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Dec 31, 2023 | 692,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 449,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 5.81 Mn |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 9.89 Mn |
| Sep 30, 2021 | 9.57 Mn |